Global Markets for Blood Plasma Products
Description
Global Markets for Blood Plasma Products
Report Scope:
This research report presents an in-depth analysis of the global blood plasma products market by product type, application, end user and geographic market. In addition, the report provides qualitative information related to the mode of delivery for blood plasma.
The report includes key blood plasma products used in various therapeutic treatments as well as an examination of the supply chain from research to manufacturing. It also features an in-depth analysis of the key companies operating in the global blood plasma products market, and it surveys patents that highlight past, current and projected global technology trends. The blood plasma products market is primarily segmented into five major categories: immunoglobulin, albumin, hyperimmune globulin, coagulation factor concentrates, and other plasma fractionation products. Immunology, oncology, pulmonology, rheumatology, transplant, neurology, hematology and other applications are explained in the report. Products based on these applications are explored in detail and their influence on R&D is examined. In the analysis based on end users, the blood plasma products market is segmented into the following: hospitals and clinics, research laboratories, academic institutions and blood transfusion centers.
In terms of geography, the report analyzes the market across North America, Europe, Asia-Pacific and the Rest of the World (RoW). Key regions like the U.S., Canada, Europe (U.K., Italy, France, Germany), China, India, Australia and Japan are highlighted in the discussion due to a high concentration of blood plasma products manufacturing companies and contract manufacturing organizations in these areas. This report includes estimates of market size using 2021 as the base year and forecasting forward to 2027. Recent products launched by blood plasma products companies are studied and listed in the report. The estimated values that are used are based on the manufacturers’ total revenues.
A detailed analysis illustrating market dynamics and market structure is incorporated in the report. The market’s supply and distribution chain is discussed in detail in order to provide an in-depth understanding of the market. Top market players, along with details about their individual business operations and segment focus as well as analyses about their revenue and strategies, are included in the report. In addition, market share analysis of leading market players, product launches and pipeline products are provided.
Report Includes:
44 data tables and 30 additional tables
An overview of the global market for blood plasma products
Analyses of global market trends with data from 2020-2022, and projections of compound annual growth rates (CAGRs) through 2027
Characterization and quantification of the global blood plasma products markets by product, application, mode of delivery, end user and geographical region
Detailed information related to mode of delivery for blood plasma
Analysis of key blood plasma products used in various therapeutic treatments as well as an examination of the supply chain from research to manufacturing
Coverage of segmentation of blood plasma products, including immunoglobulin, albumin, protease inhibitors, coagulation factor concentrates and other plasma fractionation products
In-depth analysis of the key strategies adopted by industry players, such as acquisition and geographical expansion
A look at major factors driving the growth of the global blood plasma products markets, including an organized network of donor centres and rising disease awareness and education
Profiles of the major players in the industry, including ADMA Biologics Inc., China Biologic Products Inc., Kedrion SpA, Octapharma AG, and Takeda Pharmaceutical Co. Ltd.
Companies Mentioned
ADMA BIOLOGICS INC.
BAXTER INTERNATIONAL
BIO PRODUCTS LABORATORY LTD. (BPL)
CHINA BIOLOGIC PRODUCTS INC.
CSL BEHRING
GRIFOLS INTERNATIONAL SA
INNOVATIVE RESEARCH INC.
INTAS PHARMACEUTICALS LTD.
KEDRION SPA
LFB SA
OCTAPHARMA AG
SANQUIN
TAKEDA PHARMACEUTICAL CO. LTD.
Report Scope:
This research report presents an in-depth analysis of the global blood plasma products market by product type, application, end user and geographic market. In addition, the report provides qualitative information related to the mode of delivery for blood plasma.
The report includes key blood plasma products used in various therapeutic treatments as well as an examination of the supply chain from research to manufacturing. It also features an in-depth analysis of the key companies operating in the global blood plasma products market, and it surveys patents that highlight past, current and projected global technology trends. The blood plasma products market is primarily segmented into five major categories: immunoglobulin, albumin, hyperimmune globulin, coagulation factor concentrates, and other plasma fractionation products. Immunology, oncology, pulmonology, rheumatology, transplant, neurology, hematology and other applications are explained in the report. Products based on these applications are explored in detail and their influence on R&D is examined. In the analysis based on end users, the blood plasma products market is segmented into the following: hospitals and clinics, research laboratories, academic institutions and blood transfusion centers.
In terms of geography, the report analyzes the market across North America, Europe, Asia-Pacific and the Rest of the World (RoW). Key regions like the U.S., Canada, Europe (U.K., Italy, France, Germany), China, India, Australia and Japan are highlighted in the discussion due to a high concentration of blood plasma products manufacturing companies and contract manufacturing organizations in these areas. This report includes estimates of market size using 2021 as the base year and forecasting forward to 2027. Recent products launched by blood plasma products companies are studied and listed in the report. The estimated values that are used are based on the manufacturers’ total revenues.
A detailed analysis illustrating market dynamics and market structure is incorporated in the report. The market’s supply and distribution chain is discussed in detail in order to provide an in-depth understanding of the market. Top market players, along with details about their individual business operations and segment focus as well as analyses about their revenue and strategies, are included in the report. In addition, market share analysis of leading market players, product launches and pipeline products are provided.
Report Includes:
44 data tables and 30 additional tables
An overview of the global market for blood plasma products
Analyses of global market trends with data from 2020-2022, and projections of compound annual growth rates (CAGRs) through 2027
Characterization and quantification of the global blood plasma products markets by product, application, mode of delivery, end user and geographical region
Detailed information related to mode of delivery for blood plasma
Analysis of key blood plasma products used in various therapeutic treatments as well as an examination of the supply chain from research to manufacturing
Coverage of segmentation of blood plasma products, including immunoglobulin, albumin, protease inhibitors, coagulation factor concentrates and other plasma fractionation products
In-depth analysis of the key strategies adopted by industry players, such as acquisition and geographical expansion
A look at major factors driving the growth of the global blood plasma products markets, including an organized network of donor centres and rising disease awareness and education
Profiles of the major players in the industry, including ADMA Biologics Inc., China Biologic Products Inc., Kedrion SpA, Octapharma AG, and Takeda Pharmaceutical Co. Ltd.
Companies Mentioned
ADMA BIOLOGICS INC.
BAXTER INTERNATIONAL
BIO PRODUCTS LABORATORY LTD. (BPL)
CHINA BIOLOGIC PRODUCTS INC.
CSL BEHRING
GRIFOLS INTERNATIONAL SA
INNOVATIVE RESEARCH INC.
INTAS PHARMACEUTICALS LTD.
KEDRION SPA
LFB SA
OCTAPHARMA AG
SANQUIN
TAKEDA PHARMACEUTICAL CO. LTD.
Table of Contents
144 Pages
- Chapter 1 Introduction
- 1.1 Study Goals and Objectives
- 1.2 Reasons for Doing This Study
- 1.3 Scope of Report
- 1.4 What's New in This Update?
- 1.5 Information Sources
- 1.6 Methodology
- 1.7 Intended Audience
- 1.8 Geographic Breakdown
- 1.9 Analyst's Credentials
- 1.10 BCC Custom Research
- 1.11 Related BCC Research Reports
- Chapter 2 Summary and Highlights
- 2.1 Highlights of the Market for Blood Plasma Products
- Chapter 3 Market and Technology Background
- 3.1 Introduction to Blood Plasma Products
- 3.2 Components of Blood Plasma
- 3.3 Functions of Blood Plasma
- 3.4 Blood Donation
- 3.4.1 Collection and Extraction of Blood Plasma
- 3.4.2 Fractionation Methods for Extracting Individual Components from Plasma
- 3.5 Government Regulations: FDA, International Regulatory Agencies and Medical Associations
- 3.6 Clinical Guidelines
- 3.7 Market Dynamics
- 3.7.1 Drivers
- 3.7.2 Restraints
- 3.7.3 Opportunities
- Chapter 4 Market Breakdown by Product Type
- 4.1 Overall Market Size and Forecast
- 4.2 Immunoglobulins
- 4.2.1 Market Size and Forecast by Region
- 4.2.2 Market Size and Forecast by Product Subsegment
- 4.3 Albumin
- 4.3.1 Market Size and Forecast by Region
- 4.4 Coagulation Factor Concentrates
- 4.4.1 Market Size and Forecast by Region
- 4.5 Hyperimmune Globulins
- 4.5.1 Market Size and Forecast by Region
- 4.6 Other Plasma Fractionation Products
- 4.6.1 Market Size and Forecast by Region
- Chapter 5 Market Breakdown by Application
- 5.1 Overall Market Size and Forecast
- 5.2 Neurology
- 5.2.1 Market Size and Forecast by Region
- 5.3 Immunology
- 5.3.1 Market Size and Forecast by Region
- 5.4 Oncology
- 5.4.1 Market Size and Forecast by Region
- 5.5 Transplants
- 5.5.1 Market Size and Forecast by Region
- 5.6 Hematology
- 5.6.1 Market Size and Forecast by Region
- 5.7 Rheumatology
- 5.7.1 Market Size and Forecast by Region
- 5.8 Pulmonology
- 5.8.1 Market Size and Forecast by Region
- 5.9 Others
- 5.9.1 Market Size and Forecast by Region
- Chapter 6 Market Breakdown by End User
- 6.1 Overall Market Size and Forecast
- 6.2 Hospitals and Clinics
- 6.2.1 Market Size and Forecast by Region
- 6.3 Research Laboratories
- 6.3.1 Market Size and Forecast by Region
- 6.4 Academic Institutions
- 6.4.1 Market Size and Forecast by Region
- 6.5 Blood Transfusion Centers
- 6.5.1 Market Size and Forecast by Region
- Chapter 7 Market Breakdown by Region
- 7.1 Overall Market Size and Forecast by Region
- 7.2 North America
- 7.2.1 North American Market Size and Forecast by Country
- 7.2.2 North American Market Size and Forecast by Product Type
- 7.2.3 North American Market Size and Forecast by Application
- 7.2.4 North American Market Size and Forecast by End User
- 7.3 Europe
- 7.3.1 European Market Size and Forecast by Country
- 7.3.2 European Market Size and Forecast by Product Type
- 7.3.3 European Market Size and Forecast by Application
- 7.3.4 European Market Size and Forecast by End User
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Market Size and Forecast by Country
- 7.4.2 APAC Market Size and Forecast by Product Type
- 7.4.3 APAC Market Size and Forecast by Application
- 7.4.4 APAC Market Size and Forecast by End User
- 7.5 Rest of the World
- 7.5.1 Rest of the World Market Size and Forecast by Country
- 7.5.2 RoW Market Size and Forecast by Product Type
- 7.5.3 RoW Market Size and Forecast by Application
- 7.5.4 RoW Market Size and Forecast by End User
- Chapter 8 Mode of Delivery for Blood Plasma Products
- 8.1 Infusion Solutions
- 8.2 Gels
- 8.3 Sprays
- 8.4 Biomedical Sealants
- 8.5 Other Modes of Delivery
- 8.5.1 Inhalation
- 8.5.2 Ophthalmic Drops
- Chapter 9 Patent Review and Clinical Trial Landscape
- 9.1 Patent Review
- 9.2 Clinical Trials Landscape
- Chapter 10 Impact of the COVID-19 Pandemic on the Market for Blood Plasma Products
- 10.1 Impact on the Blood Plasma Product Manufacturers
- Chapter 11 Competitive Landscape
- 11.1 Overview
- 11.2 Major Players and Market Shares
- 11.3 Porter's Five Forces Analysis of the Market for Blood Plasma Products
- 11.3.1 Bargaining Power of Suppliers
- 11.3.2 Bargaining Power of Buyers
- 11.3.3 The Threat of New Suppliers
- 11.3.4 Threat of Substitutes
- 11.3.5 Competitive Rivalry/Degree of Competition
- 11.4 Major Developments
- 11.5 Product Launches
- 11.6 Mergers and Acquisitions
- 11.7 Business Expansions
- 11.8 Agreements and Collaborations
- Chapter 12 Company Profiles
- ADMA BIOLOGICS INC.
- BAXTER INTERNATIONAL
- BIO PRODUCTS LABORATORY LTD. (BPL)
- CHINA BIOLOGIC PRODUCTS INC.
- CSL BEHRING
- GRIFOLS INTERNATIONAL SA
- INNOVATIVE RESEARCH INC.
- INTAS PHARMACEUTICALS LTD.
- KEDRION SPA
- LFB SA
- OCTAPHARMA AG
- SANQUIN
- TAKEDA PHARMACEUTICAL CO. LTD.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
